Barry J Byrne

11PUBLICATIONS
64CO-AUTHORS
Gene and molecular therapyMolecular targetsMetabolic medicineMechanobiologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 19, 2026
Sirolimus for the treatment of steroid-refractory hepatotoxicity following AAV gene therapy in patients with Duchenne muscular dystrophy.

Carmen Leon-Astudillo, Stephanie M Salabarria, Christina B Chadwick

|Feb 18, 2026
AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy.

Emanuela Pannia, Rebecca Simonian, Nesrin Sabha

|Oct 14, 2025
Integrated multi-omics mapping of mitochondrial dysfunction and substrate preference in Barth syndrome cardiac tissue.

Bauke V Schomakers, Adriana S Passadouro, Maria M Trętowicz

|Apr 10, 2025
Quantification and comparison of anti-AAV9 and anti-AAVrh74 antibodies in plasma and human milk: Implications for AAV-based gene therapy candidacy.

Carmen Leon-Astudillo, Kirsten Coleman, Stephanie M Salabarria

|Mar 17, 2025
Overexpression of Wild-Type TMEM43 Improves Cardiac Function in Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Laura Lalaguna, María Arévalo-Núñez de Arenas, Marina López-Olañeta

|Feb 17, 2025
Correction: Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).

Barry J Byrne, Benedikt Schoser, Priya S Kishnani

Pageof 2

Frequent Collaborators

4 joint publications

Manuela Corti

3 joint publications

Carmen Leon-Astudillo

3 joint publications

Kirsten E Coleman

2 joint publications

Stephanie M Salabarria